164 related articles for article (PubMed ID: 2167103)
21. Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: report of a fatal case.
Manian FA; Kindred M; Fulling KH
Clin Infect Dis; 1995 Oct; 21(4):986-8. PubMed ID: 8645852
[TBL] [Abstract][Full Text] [Related]
22. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
Balfour HH; McMonigal KA; Bean B
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
[TBL] [Abstract][Full Text] [Related]
23. Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
Meenken C; van den Horn GJ; de Smet MD; van der Meer JT
Ann Neurol; 1998 Apr; 43(4):534-6. PubMed ID: 9546338
[TBL] [Abstract][Full Text] [Related]
24. Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient.
Gueudry J; Boutolleau D; Gueudin M; Burrel S; Miri A; Bodaghi B; Muraine M
J Clin Virol; 2013 Sep; 58(1):318-20. PubMed ID: 23756055
[TBL] [Abstract][Full Text] [Related]
25. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
Hatchette T; Tipples GA; Peters G; Alsuwaidi A; Zhou J; Mailman TL
Pediatr Infect Dis J; 2008 Jan; 27(1):75-7. PubMed ID: 18162946
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
27. Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome.
Gilson IH; Barnett JH; Conant MA; Laskin OL; Williams J; Jones PG
J Am Acad Dermatol; 1989 Apr; 20(4):637-42. PubMed ID: 2715411
[TBL] [Abstract][Full Text] [Related]
28. Varicella-zoster-specific immune responses in acute herpes zoster during a placebo-controlled trial of oral acyclovir therapy.
Mitchell CD; Gehrz RC; Balfour HH
Diagn Microbiol Infect Dis; 1986 Jul; 5(2):113-26. PubMed ID: 3013495
[TBL] [Abstract][Full Text] [Related]
29. Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment.
Shiraki K; Takemoto M; Daikoku T
Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1415-1425. PubMed ID: 33853490
[No Abstract] [Full Text] [Related]
30. Acyclovir-resistant varicella zoster responsive to foscarnet.
Smith KJ; Kahlter DC; Davis C; James WD; Skelton HG; Angritt P
Arch Dermatol; 1991 Jul; 127(7):1069-71. PubMed ID: 1648341
[No Abstract] [Full Text] [Related]
31. Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.
Breton G; Fillet AM; Katlama C; Bricaire F; Caumes E
Clin Infect Dis; 1998 Dec; 27(6):1525-7. PubMed ID: 9868672
[TBL] [Abstract][Full Text] [Related]
32. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
33. Quantification of circulating varicella-zoster virus DNA for follow-up in a case of visceral varicella-zoster infection ameliorated with intravenous acyclovir.
Ishizawa J; Fujita H; Iguchi M; Tachibana T; Taguchi J; Ishigatsubo Y
Int J Hematol; 2007 Apr; 85(3):242-5. PubMed ID: 17483062
[TBL] [Abstract][Full Text] [Related]
34. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
35. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome.
Saint-Léger E; Caumes E; Breton G; Douard D; Saiag P; Huraux JM; Bricaire F; Agut H; Fillet AM
Clin Infect Dis; 2001 Dec; 33(12):2061-7. PubMed ID: 11702291
[TBL] [Abstract][Full Text] [Related]
36. [Herpes zoster and acyclovir in normal and deficient general immunity, also that due to AIDS].
van Joost T
Ned Tijdschr Geneeskd; 1990 Jun; 134(22):1080-4. PubMed ID: 2191225
[No Abstract] [Full Text] [Related]
37. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
Sall RK; Kauffman CL; Levy CS
Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
[TBL] [Abstract][Full Text] [Related]
38. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
[TBL] [Abstract][Full Text] [Related]
39. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
Daikoku T; Shiraki K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
[No Abstract] [Full Text] [Related]
40. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
